Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
J Am Geriatr Soc. 2011 Jul;59(7):1217-24. doi: 10.1111/j.1532-5415.2011.03472.x. Epub 2011 Jun 30.
To examine the associations between insulin resistance and changes in body composition in older men without diabetes mellitus.
Longitudinal cohort study of older men participating in the Osteoporotic Fractures in Men (MrOS) study.
Six U.S. clinical centers.
Three thousand one hundred thirty-two ambulatory men aged 65 and older at baseline.
Baseline insulin resistance was calculated for men without diabetes mellitus using the homeostasis model assessment of insulin resistance (HOMA-IR). Total lean, appendicular lean, total fat, and truncal fat mass were measured using dual energy X-ray absorptiometry scans at baseline and 4.6 ± 0.3 years later in 3,132 men with HOMA-IR measurements.
There was greater loss of weight, total lean mass, and appendicular lean mass and less gain in total fat mass and truncal fat mass with increasing quartiles of HOMA-IR (P<.001 for trend). Insulin-resistant men in the highest quartile had higher odds of 5% or more loss of weight (odds ratio (OR)=1.88, 95% confidence interval (CI)=1.46-2.43), total lean mass (OR=2.09, 95% CI=1.60-2.73) and appendicular lean mass (OR=1.57, 95% CI=1.27-1.95) and lower odds of 5% or more gain in total fat mass (OR=0.56, 95% CI=0.45-0.68) and truncal fat mass (OR=0.52, 95% CI=0.42-0.64) than those in the lowest quartile. These findings remained significant after accounting for age, site, baseline weight, physical activity, and change in physical activity. These associations were also independent of other metabolic syndrome features and medications.
Greater lean mass loss and lower fat mass gain occurred in insulin-resistant men without diabetes mellitus than in insulin-sensitive men. Insulin resistance may accelerate age-related sarcopenia.
研究无糖尿病的老年男性中胰岛素抵抗与身体成分变化之间的关系。
参与男性骨质疏松症研究(MrOS)的老年男性的纵向队列研究。
美国六个临床中心。
3132 名年龄在 65 岁及以上的门诊男性,基线时无糖尿病。
无糖尿病的男性使用稳态模型评估胰岛素抵抗(HOMA-IR)计算胰岛素抵抗的基线值。在 3132 名有 HOMA-IR 测量值的男性中,使用双能 X 射线吸收法在基线和 4.6±0.3 年后测量总瘦体重、四肢瘦体重、总脂肪量和躯干脂肪量。
随着 HOMA-IR 四分位间距的增加,体重、总瘦体重和四肢瘦体重的损失更大,总脂肪量和躯干脂肪量的增加更少(趋势 P<.001)。HOMA-IR 最高四分位数的胰岛素抵抗男性体重下降 5%或更多的几率更高(比值比(OR)=1.88,95%置信区间(CI)=1.46-2.43),总瘦体重(OR=2.09,95% CI=1.60-2.73)和四肢瘦体重(OR=1.57,95% CI=1.27-1.95),而总脂肪量增加 5%或更多的几率更低(OR=0.56,95% CI=0.45-0.68)和躯干脂肪量(OR=0.52,95% CI=0.42-0.64)比最低四分位数的男性。这些发现在考虑年龄、地点、基线体重、体力活动和体力活动变化后仍然显著。这些关联也独立于其他代谢综合征特征和药物。
无糖尿病的胰岛素抵抗男性比胰岛素敏感男性的瘦体重损失更大,脂肪量增加更少。胰岛素抵抗可能加速与年龄相关的肌肉减少症。